Global Gastrointestinal Therapeutics and Diagnostics Market Research Report 2023

Publisher Name :
Date: 27-Jan-2023
No. of pages: 84
Inquire Before Buying

Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.

Highlights

The global Gastrointestinal Therapeutics and Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Gastrointestinal Therapeutics and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Gastrointestinal Therapeutics and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Gastrointestinal Therapeutics and Diagnostics in Gastroenteritis is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Gastrointestinal Therapeutics and Diagnostics include Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals and Takeda Pharmaceutical Company, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Therapeutics and Diagnostics.

The Gastrointestinal Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gastrointestinal Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastrointestinal Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Abbott Laboratories

- AstraZeneca

- Eisai

- Johnson & Johnson

- Salix Pharmaceuticals

- Takeda Pharmaceutical Company

Segment by Type

- Diagnostics

- Therapeutics

Segment by Application

- Gastroenteritis

- GI Bleeding

- Irritable Bowel Syndrome

- Peptic Ulcer Disease (PUD)

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastrointestinal Therapeutics and Diagnostics companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Gastrointestinal Therapeutics and Diagnostics Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Gastroenteritis
1.3.3 GI Bleeding
1.3.4 Irritable Bowel Syndrome
1.3.5 Peptic Ulcer Disease (PUD)
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Perspective (2018-2029)
2.2 Gastrointestinal Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Gastrointestinal Therapeutics and Diagnostics Market Dynamics
2.3.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends
2.3.2 Gastrointestinal Therapeutics and Diagnostics Market Drivers
2.3.3 Gastrointestinal Therapeutics and Diagnostics Market Challenges
2.3.4 Gastrointestinal Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
3.4 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2022
3.5 Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2024-2029)
5 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
6.2 North America Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
6.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
7.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
9.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Introduction
11.2.4 AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Eisai
11.3.1 Eisai Company Detail
11.3.2 Eisai Business Overview
11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Introduction
11.3.4 Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.3.5 Eisai Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Introduction
11.4.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Detail
11.5.2 Salix Pharmaceuticals Business Overview
11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Introduction
11.5.4 Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.5.5 Salix Pharmaceuticals Recent Development
11.6 Takeda Pharmaceutical Company
11.6.1 Takeda Pharmaceutical Company Company Detail
11.6.2 Takeda Pharmaceutical Company Business Overview
11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Introduction
11.6.4 Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.6.5 Takeda Pharmaceutical Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2018-2023)
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2024-2029)
Table 10. Gastrointestinal Therapeutics and Diagnostics Market Trends
Table 11. Gastrointestinal Therapeutics and Diagnostics Market Drivers
Table 12. Gastrointestinal Therapeutics and Diagnostics Market Challenges
Table 13. Gastrointestinal Therapeutics and Diagnostics Market Restraints
Table 14. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players (2018-2023)
Table 16. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2022)
Table 17. Ranking of Global Top Gastrointestinal Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
Table 21. Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2018-2023)
Table 25. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2024-2029)
Table 27. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2018-2023)
Table 29. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2024-2029)
Table 31. North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product
Table 49. Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product
Table 54. AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Eisai Company Detail
Table 57. Eisai Business Overview
Table 58. Eisai Gastrointestinal Therapeutics and Diagnostics Product
Table 59. Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 60. Eisai Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product
Table 64. Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Salix Pharmaceuticals Company Detail
Table 67. Salix Pharmaceuticals Business Overview
Table 68. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product
Table 69. Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 70. Salix Pharmaceuticals Recent Development
Table 71. Takeda Pharmaceutical Company Company Detail
Table 72. Takeda Pharmaceutical Company Business Overview
Table 73. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product
Table 74. Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 75. Takeda Pharmaceutical Company Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Diagnostics Features
Figure 4. Therapeutics Features
Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2022 VS 2029
Figure 7. Gastroenteritis Case Studies
Figure 8. GI Bleeding Case Studies
Figure 9. Irritable Bowel Syndrome Case Studies
Figure 10. Peptic Ulcer Disease (PUD) Case Studies
Figure 11. Others Case Studies
Figure 12. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players in 2022
Figure 17. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue in 2022
Figure 19. North America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2029)
Figure 21. United States Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2029)
Figure 25. Germany Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2018-2029)
Figure 33. China Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2029)
Figure 41. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2029)
Figure 45. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 49. Eisai Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 51. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 52. Takeda Pharmaceutical Company Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global Analytical Standards Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 108
    The Analytical Standards market revenue was 2055.18 Million USD in 2022, and will reach 3275.31 Million USD in 2028, with a CAGR of 8.08% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Analytical Standards industry, and breaks down according to the type, application, and consumption area of Analytical Standards. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • Global Human Serum Albumin Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 105
    The Human Serum Albumin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Human Serum Albumin industry, and breaks down according to the type, application, and consumption area of Human Serum Albumin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......
  • Global Pharmaceutical Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 107
    The Pharmaceutical market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pharmaceutical industry, and breaks down according to the type, application, and consumption area of Pharmaceutical. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading c......
  • Global Human Albumin Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 129
    The Human Albumin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Human Albumin industry, and breaks down according to the type, application, and consumption area of Human Albumin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading comp......
  • Global Softgel Capsules Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 103
    The Softgel Capsules market revenue was 9672.28 Million USD in 2022, and will reach 15017.42 Million USD in 2028, with a CAGR of 7.61% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Softgel Capsules industry, and breaks down according to the type, application, and consumption area of Softgel Capsules. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and desc......
  • Global Soft Gelatin Capsules Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 120
    Soft gelatin capsules, also known as soft gels, are still the leading product format in dietary supplements. Soft gelatin capsules is ideal for both the dietary supplement and pharmaceutical markets The Soft Gelatin Capsules market revenue was 4377.06 Million USD in 2022, and will reach 6272.58 Million USD in 2028, with a CAGR of 6.18% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Soft Gelatin Capsules industry, a......
  • Global Pharma & Cosmetics Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 101
    The Pharma & Cosmetics market revenue was 1863641.54 Million USD in 2022, and will reach 2263346.26 Million USD in 2028, with a CAGR of 3.29% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pharma & Cosmetics industry, and breaks down according to the type, application, and consumption area of Pharma & Cosmetics. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • Global Oncology (Anti-cancer Drugs) Market Research Report 2023
    Published: 16-Mar-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Oncology (Anti-cancer Drugs) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 202......
  • Global Pigskin Gelatin Market Research Report 2023
    Published: 16-Mar-2023        Price: US 2900 Onwards        Pages: 113
    Gelatin is a protein obtained by boiling skin, tendons, ligaments, and/or bones with water. It is usually obtained from cows or pigs. Skin gelatin is made of fresh animal skin. Highlights The global Pigskin Gelatin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. The rese......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs